Hang Yin
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 15
- MicroRNA in disease regulation 11
- Cancer, Hypoxia, and Metabolism 9
- Immunology top 5%
- Immunotherapy and Immune Responses 8
- Biomedical Engineering top 2%
- Nanoplatforms for cancer theranostics 10
- Biomaterials top 5%
- Molecular Biology top 5%
- RNA modifications and cancer 10
- Circular RNAs in diseases 10
- RNA Interference and Gene Delivery 6
- Journals
- Nature Communications (3 papers)SHILAP Revista de lepidopterología (1 paper)ACS Nano (2 papers)
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Hang Yin
103 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 888
- Immunology 730
- Biomedical Engineering 1.2k
- Biomaterials 363
- Molecular Biology 1.6k
Countries citing papers authored by Hang Yin
This map shows the geographic impact of Hang Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hang Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hang Yin more than expected).
Fields of papers citing papers by Hang Yin
This network shows the impact of papers produced by Hang Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hang Yin. The network helps show where Hang Yin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hang Yin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 26 | |
| 9 | 2023 | 26 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 43 | |
| 14 | 2023 | 39 | |
| 15 | 2021 | 2 | |
| 16 | 2020 | 17 | |
| 17 | 2020 | 110 | |
| 18 | 2016 | 66 | |
| 19 | 2013 | 1 | |
| 20 | 2000 | 65 |
About Hang Yin
Hang Yin is a scholar working on Cancer Research, Immunology and Pulmonary and Respiratory Medicine, having authored 109 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (15 papers), MicroRNA in disease regulation (11 papers), Nanoplatforms for cancer theranostics (10 papers), RNA modifications and cancer (10 papers), Circular RNAs in diseases (10 papers), Cancer, Hypoxia, and Metabolism (9 papers), Immunotherapy and Immune Responses (8 papers) and RNA Interference and Gene Delivery (6 papers). The work is most often cited by research in Cancer Research (888 citations), Immunology (730 citations) and Biomedical Engineering (1.2k citations). Hang Yin has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Jian You, Lihua Luo, Mengshi Jiang, Chunqi Zhu, Yongzhong Du, Xiaoling Yuan, Bing Qin, Junlei Zhang, Jie Yang and Wei Li. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.